Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 8/2012

Open Access 01.08.2012 | Editorial

One problem is the risk of the next: a vote for early detection and preventive intervention of coexisting psychopathology

verfasst von: Aribert Rothenberger

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 8/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
As the readers of this Journal know ECAP and ESCAP (European Society for Child and Adolescent Psychiatry) jointly award the “ECAP-ADHD-Paper of the Year”1 at a European meeting for Child and Adolescent Psychiatry [13]. For the winners of the year 2011, the event chosen was the Eunethydis2 2nd International ADHD Conference in Barcelona (23–25 May, 2012). Two papers out of the 18 published deserved the special attention of the Jury:
Imeraj L, Antrop I, Roeyers H, Deschepper E, Bal S, Deboutte D. Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD. Eur Child Adolesc Psychiatry (2011) 20:381–392
Kröger A, Hänig S, Seitz C, Palmason H, Meyer J, Freitag CM. Risk factors of autistic symptoms in children with ADHD. Eur Child Adolesc Psychiatry (2011) 20:561–570
Both studies reported of behavioural risk factors which might trigger problem behaviour in a kind of domino-effect. The work of Imeraj et al. [6] faces two neglected but practically important issues on ADHD, namely, circadiane sleep-wake behaviour and autonomic arousal. Both are basic subcortical functions which may influence higher order cognitive abilities and thus confound many studies on attention in ADHD. The presented data on 24-h heart-rate, reflecting an autonomic imbalance in ADHD, might be considered also in the light of the discussion about cardiovascular side effects of medication in ADHD. Especially, if it is true that already before the long-term use of stimulants, the overall heart-rate levels are increased in children with ADHD (for critical evaluation see also European Guidelines like [1, 5, 15]. Hence, early diagnostics and careful monitoring seems necessary. Kröger et al. [8] focus on the daily clinical issue of differential diagnosis and/or comorbidity of ADHD and increased autistic symptoms. Also, these subclinical symptoms may be confounders in research. Hence, Kröger et al. described risk factors of these increased autistic symptoms in ADHD. Their findings are indicative of possible genetic (maternal autistic traits) as well as environmental factors. The relevance of psychosocial risk factors (e.g. intra-familial discord, abnormal parenting, isolated family) was shown for the first time in this respect and suggests for the future to combine genetic and clinical research more directly in one study, but also to psychosocially support these families very early in their problem solving approaches.
Three original articles of this ECAP issue underline the view of clinical risk factors as triggers for further psychopathological signs.
For example, children of parents with chronic medical condition displayed a slightly increased risk for internalizing problems [14]. In the Dutch normative sample of the YSR, only 8 % of girls and 9 % of boys were categorized as clinical cases, while in this sample of 160 adolescents 12 % of girls and 11.7 % of boys were found. Although the evaluated anxious/depressed scale of the YSR predicts a DSM-IV disorder only moderately, preventive activities seem to be worthy since ongoing stress and thus chronic elevation of cortisol [3] by thoughts of loss, bereavement and unpredictability of parental health may lead to greater emotional problems. Fortunately, the adolescents of this sample displayed few externalizing problems. Here as well as in the study on ADHD and autism of Kröger et al. [8] the well-known negative impact of psychosocial risks was displayed. On the other hand, there exists evidence that a first psychopathological condition of an individual may form the risk for the appearance and/or severity of a next one.
In a large European school survey, based on 45.086 16-year-old adolescents from 16 countries, substance use (tranquillizer, tobacco, alcohol, cannabis) was found as risk factor for self-reported suicide attempts [7]. Remarkably, “the odds ratio of reporting a suicide attempt approximately doubled for every additional substance use”. The authors should be supported when they say, that we, e.g. mental health professionals and public health decision makers, need to shape existing prevention policies. As with most of the adolescents suffering from internalizing problems they are often neglected because of the demanding externalizing problems of their classmates. We need to better listen to the silence.
Finally, the complex neuropsychiatric disorder of Tourette syndrome (see also the European Guidelines in this Journal: [2, 10, 12, 16]) reflects some risks within itself, since its comorbidity-profile (especially while changing during the course of illness) makes it a challenging case for the patient and the physician [4, 11, 17].
Lebowitz et al. [9] clarify that chronic tic disorders (CTD) with coexisting obsessive–compulsive disorder is a more severe subtype of CTD, characterized not only by more severe tics but also by e.g. poorer global functioning. Further, similar to the situation of additional substance use [7], Wanderer et al. [17] found in CTD that the presence of comorbid OCD was associated with higher rates of additional comorbid diagnoses; i.e. the earlier the risky obsessive–compulsive traits can be detected in CTD and treated, the better is the precondition for the future course of CTD and patient’s psychosocial functioning/development.
In sum, our view on risk factors should not be restricted to environmental or genetic factors. Moreover, the risks within the complex, usually comorbid problem situation of a child psychiatric disorder deserves greater attention in order to prevent exacerbation while detecting and treating the risks quite early in time. In the long run, the effort would be paralleled by a positive cost-benefit-ratio for both, the patients and the society.

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Psychiatrie

Kombi-Abonnement

Mit e.Med Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Psychiatrie, den Premium-Inhalten der psychiatrischen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Fußnoten
1
Sponsored by Shire-Germany.
 
2
European Network on Hyperkinetic Disorders.
 
Literatur
1.
Zurück zum Zitat Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders: a systematic review and European guideline. Eur Child Adolesc Psychiatry 15:476–498PubMedCrossRef Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders: a systematic review and European guideline. Eur Child Adolesc Psychiatry 15:476–498PubMedCrossRef
2.
Zurück zum Zitat Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 20:155–171PubMedCrossRef Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 20:155–171PubMedCrossRef
3.
Zurück zum Zitat Christiansen H, Oades RD, Psychogiou L, Hauffa BP, Sonuga-Barke EJ (2010) Does the cortisol response to stress mediate the link between expressed emotion and oppositional behavior in attention-deficit/hyperactivity-disorder (ADHD)? Behav Brain Funct 6:45PubMedCrossRef Christiansen H, Oades RD, Psychogiou L, Hauffa BP, Sonuga-Barke EJ (2010) Does the cortisol response to stress mediate the link between expressed emotion and oppositional behavior in attention-deficit/hyperactivity-disorder (ADHD)? Behav Brain Funct 6:45PubMedCrossRef
4.
Zurück zum Zitat Freeman R and the Tourette Syndrome International Database Consortium (2007) Tic disorders and ADHD—answers from a world-wide clinical data set on Tourette Syndrome. Eur Child Adolesc Psychiatry 16(suppl 1):i15–i23 Freeman R and the Tourette Syndrome International Database Consortium (2007) Tic disorders and ADHD—answers from a world-wide clinical data set on Tourette Syndrome. Eur Child Adolesc Psychiatry 16(suppl 1):i15–i23
5.
Zurück zum Zitat Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E, for the European Guidelines Group (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37PubMedCrossRef Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E, for the European Guidelines Group (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37PubMedCrossRef
6.
Zurück zum Zitat Imeraj L, Antrop I, Roeyers H, Deschepper E, Bal S, Deboutte D (2011) Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD. Eur Child Adolesc Psychiatry 20:381–392PubMedCrossRef Imeraj L, Antrop I, Roeyers H, Deschepper E, Bal S, Deboutte D (2011) Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD. Eur Child Adolesc Psychiatry 20:381–392PubMedCrossRef
7.
Zurück zum Zitat Kokkevi A, Richardson C, Olszewski D, Matias J, Monshouwer K, Bjarnason T (2012) Multiple substance use and self-reported suicide attempts by adolescents in 16 European countries. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-012-0276-7 Kokkevi A, Richardson C, Olszewski D, Matias J, Monshouwer K, Bjarnason T (2012) Multiple substance use and self-reported suicide attempts by adolescents in 16 European countries. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-012-0276-7
8.
Zurück zum Zitat Kröger A, Hönig S, Seitz C, Palmason H, Meyer J, Freitag CM (2011) Risk factors of autistic symptoms in children with ADHD. Eur Child Adolesc Psychiatry 20:561–570PubMedCrossRef Kröger A, Hönig S, Seitz C, Palmason H, Meyer J, Freitag CM (2011) Risk factors of autistic symptoms in children with ADHD. Eur Child Adolesc Psychiatry 20:561–570PubMedCrossRef
9.
Zurück zum Zitat Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ, the Tourette Syndrome Study Group, Kurlan MR; Leckman JF (2012) Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-012-0278-5 Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ, the Tourette Syndrome Study Group, Kurlan MR; Leckman JF (2012) Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-012-0278-5
10.
Zurück zum Zitat Müller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vandewalle V, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 20:209–217PubMedCrossRef Müller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vandewalle V, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 20:209–217PubMedCrossRef
11.
Zurück zum Zitat Roessner V, Becker A, Freeman R, Rothenberger A, the Tourette Syndrome International Database Consortium (2007) Developmental psychopathology concerning the association of tic disorders and ADHD. Eur Child Adolesc Psychiatry 16(suppl 1):i23–i35 Roessner V, Becker A, Freeman R, Rothenberger A, the Tourette Syndrome International Database Consortium (2007) Developmental psychopathology concerning the association of tic disorders and ADHD. Eur Child Adolesc Psychiatry 16(suppl 1):i23–i35
12.
Zurück zum Zitat Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173–196PubMedCrossRef Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173–196PubMedCrossRef
13.
Zurück zum Zitat Rothenberger A (2011) Supporting researchers: mentoring and awards of the journal. Eur Child Adolesc Psychiatry 20:331–332PubMedCrossRef Rothenberger A (2011) Supporting researchers: mentoring and awards of the journal. Eur Child Adolesc Psychiatry 20:331–332PubMedCrossRef
14.
Zurück zum Zitat Sieh DS, Visser-Meily JMA, Oort FJ, Meijer AM (2012) Risk factors for problem behavior in adolescents of parents with a chronic medical condition. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-012-0279-4 Sieh DS, Visser-Meily JMA, Oort FJ, Meijer AM (2012) Risk factors for problem behavior in adolescents of parents with a chronic medical condition. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-012-0279-4
15.
Zurück zum Zitat Taylor E, Doepfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first update. Eur Child Adolesc Psychiatry 13:7–30CrossRef Taylor E, Doepfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first update. Eur Child Adolesc Psychiatry 13:7–30CrossRef
16.
Zurück zum Zitat Verdellen C, van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 20:197–207PubMedCrossRef Verdellen C, van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 20:197–207PubMedCrossRef
17.
Zurück zum Zitat Wanderer S, Roessner V, Freeman R, Bock N, Rothenberger A, Becker A (2012) Relationship of obsessive-compulsive disorder to age-related comorbidity in children and adolescents with Tourette syndrome. J Dev Behav Pediat 33(2):124–133 Wanderer S, Roessner V, Freeman R, Bock N, Rothenberger A, Becker A (2012) Relationship of obsessive-compulsive disorder to age-related comorbidity in children and adolescents with Tourette syndrome. J Dev Behav Pediat 33(2):124–133
Metadaten
Titel
One problem is the risk of the next: a vote for early detection and preventive intervention of coexisting psychopathology
verfasst von
Aribert Rothenberger
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 8/2012
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-012-0302-9

Weitere Artikel der Ausgabe 8/2012

European Child & Adolescent Psychiatry 8/2012 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.